- Biomarker developer Oxford BioDynamics said it had appointed current director Peter Pack as its new chairman.

Interim chairman Stephen Diggle would transition to the role of non-executive director.

Pack, who joined the board in April, 2019, was co-founder and chief executive of MTM laboratories, now part of Roche Diagnostics, and between 2015 and 2019 headed therapeutics company Crescendo Biologics.

At 2:08pm: [LON:OBD] Oxford Biodynamics Plc share price was -1.75p at 78.25p

Story provided by